Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsA purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyHSP90 inhibitors decrease AID levels and activity in mice and in human cells.Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignanciesIntracellular antigens as targets for antibody based immunotherapy of malignant diseases.AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells.Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study.The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9.Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90
P2860
Q28075606-972CD447-7CA7-4E2B-886B-2E4C85C0F805Q33588432-45D3224B-C9A3-4703-9ABF-719B814A5A6DQ33688577-46763324-FAB1-425E-92AE-031C542BAE04Q34360164-654F0CAB-8617-4052-B1DD-5D857891799EQ35952172-B1075CD0-A7E5-4BD7-B6C5-8B2399674913Q36020841-D598169F-4908-4707-A73F-6594891DF46CQ37398843-5DA72EE3-77EA-47ED-A09F-E58877C0166FQ38166527-19E8712B-97B5-484E-BAD5-A29A972792B2Q38644355-E6346CCA-8C77-4A56-9001-BB87883365A9Q38925954-60DDE63A-4305-4771-8E8C-14FD04C65764Q39814133-56AA06D1-87A2-494B-8BCE-5C0B7AD02271Q43490126-DCAD2FF7-0684-4F33-8E39-A3F621989DACQ53603846-206D7B09-9136-4282-A760-17EE83C58F69Q58709100-F7A81BE3-ABF1-4169-9B02-FFE658A413C7
P2860
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
@en
type
label
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
@en
prefLabel
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
@en
P2093
P2860
P1433
P1476
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
@en
P2093
Anas Younes
Coralyn Atwell
George Z Rassidakis
Georgios V Georgakis
Jose R Valbuena
L Jeffrey Medeiros
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800459
P577
2005-10-01T00:00:00Z
P5875
P6179
1047282417